While I do not doubt the integrity of the good folks at the FDA, it is unclear to me that they could in any way protect against the real conflict of interest in McKinsey telling the opioid makers what the folks at the FDA were thinking, doing or being advised to do, or giving the manufacturers advice predicated on that knowledge.